Skip to content

Sign in Start free

Create your free account

Loading your page…

We care for the people who care.

No ads. No selling of your data. No third-party trackers.

Apps

Prognia
Ward
Suture
Osler

Library

Guidelines
Medicines
Articles
Calculators
Explore decks
Blog

Prognia

About
Pricing
Contact

Support us

Founders Wall

© 2026 Prognia · Amsterdam, the NetherlandsPrivacy TermsExchangeRate-API

Medicines · US (FDA)
Antipsychotics

FDA 2007

Other antipsychotics

Invega

Approved 27 Apr 2007OralTablet, extended release

The FDA lists this product in 9 strengths and forms.

Official labelAsk Osler about it

On this page

Composition
Strengths and forms
Official product information

The table holds no label text for this product yet, only the facts beside it. The official product information has the full text.

Composition

Active ingredients: PALIPERIDONE 3MG

Strengths and forms

The FDA lists each strength of a product separately; these pages share one label.

PALIPERIDONE 12MG · Tablet, extended releaseNDA022043-004 · Prescription
PALIPERIDONE 6MG · Tablet, extended releaseNDA022043-002 · Prescription
PALIPERIDONE 9MG · Tablet, extended releaseNDA022043-003 · Prescription
PALIPERIDONE 3MG · Tablet, extended releaseThis page
PALIPERIDONE 12MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet, extended releaseNDA021999-004 · Discontinued
PALIPERIDONE 6MG · Tablet, extended releaseNDA021999-002 · Prescription
PALIPERIDONE 9MG · Tablet, extended releaseNDA021999-003 · Prescription
PALIPERIDONE 3MG · Tablet, extended releaseNDA021999-001 · Prescription
PALIPERIDONE 1.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet, extended releaseNDA021999-006 · Discontinued

Official product information

More in antipsychotics

Paliperidone PalmitateInjectable

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Drugs@FDA lists the approved labels, letters and reviews for application NDA022043.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Brand name: Invega
Active substance: paliperidone
Drug class: Other antipsychotics
Group: Antipsychotics
Route: Oral
Dosage form: Tablet, extended release
Applicant: Janssen LP
Status: Prescription
FDA approval: 27 Apr 2007
Application: NDA022043-001
RxCUI: 686438

Guidelines

Guidelines in psychiatry293 guidelines in the library

FDA 2025

Mezofyaripiprazole · Film

FDA 2025LumateperoneCapsule

FDA 2023RisperidonePowder

FDA 2023Uzedyrisperidone · Suspension, extended release

FDA 2022Cariprazine HydrochlorideCapsule

FDA 2021BrexpiprazoleTablet

FDA 2021Lybalviolanzapine · Tablet

FDA 2021PimavanserinCapsule

FDA 2020Asenapine MaleateTablet

FDA 2019Caplytalumateperone tosylate · Capsule

FDA 2019Secuadoasenapine · System

FDA 2018Nuplazidpimavanserin tartrate · Capsule

FDA 2017Abilify Mycite Kitaripiprazole · Tablet

FDA 2016Quetiapine FumarateTablet, extended release

FDA 2015PimozideTablet

FDA 2015Vraylarcariprazine hydrochloride · Capsule

FDA 2015ClozapineTablet, orally disintegrating